Literature DB >> 17559499

An orthotopic floor-of-mouth model for locoregional growth and spread of human squamous cell carcinoma.

B Henson1, F Li, D D Coatney, T E Carey, R S Mitra, K L Kirkwood, N J D'Silva.   

Abstract

The molecular investigation of head and neck cancer targets requires the utilization and optimization of established animal models to characterize the effects of gene transcription and protein expression on invasion and metastasis. Floor-of-the-mouth murine models have been developed to study tumor growth, invasion, and metastasis of murine squamous cell carcinoma (SCC) cells in immunocompetent mice and invasion and metastasis of human SCC cells in nude mice. However, there are tumor cell lines that do not produce tumors in mice, using standard techniques, thus reducing the utility of the model to study specific genetic or treatment conditions. Furthermore, these techniques require large tumor volumes raising the possibility of airway compromise. In this report, we detail significant modifications to the orthotopic floor-of-mouth murine model for human SCC to facilitate predictable growth of a large panel of University of Michigan SCC cell lines. Furthermore, we describe the use of bioluminescence and micro-computed tomography to monitor tumor growth and bony invasion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17559499     DOI: 10.1111/j.1600-0714.2007.00549.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  21 in total

1.  The G protein-coupled receptor GALR2 promotes angiogenesis in head and neck cancer.

Authors:  Rajat Banerjee; Elizabeth A Van Tubergen; Christina S Scanlon; Robert Vander Broek; Joel P Lints; Min Liu; Nickole Russo; Ronald C Inglehart; Yugang Wang; Peter J Polverini; Keith L Kirkwood; Nisha J D'Silva
Journal:  Mol Cancer Ther       Date:  2014-02-25       Impact factor: 6.261

2.  Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma.

Authors:  Chelsea K Martin; Wessel P Dirksen; Sherry T Shu; Jillian L Werbeck; Nanda K Thudi; Mamoru Yamaguchi; Tobie D Wolfe; Kristin N Heller; Thomas J Rosol
Journal:  Oral Oncol       Date:  2012-01-21       Impact factor: 5.337

3.  Hypoxia-induced autophagic response is associated with aggressive phenotype and elevated incidence of metastasis in orthotopic immunocompetent murine models of head and neck squamous cell carcinomas (HNSCC).

Authors:  Nadarajah Vigneswaran; Jean Wu; Anren Song; Ananth Annapragada; Wolfgang Zacharias
Journal:  Exp Mol Pathol       Date:  2011-01-12       Impact factor: 3.362

4.  In vivo invasion of head and neck squamous cell carcinoma cells does not require macrophages.

Authors:  Tatiana Smirnova; Alfred Adomako; Joseph Locker; Nico Van Rooijen; Michael B Prystowsky; Jeffrey E Segall
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

5.  Urinary-type plasminogen activator receptor/alpha 3 beta 1 integrin signaling, altered gene expression, and oral tumor progression.

Authors:  Supurna Ghosh; Jennifer Koblinski; Jeffrey Johnson; Yueying Liu; Aaron Ericsson; J Wade Davis; Zonggao Shi; Matthew J Ravosa; Susan Crawford; Shellaine Frazier; M Sharon Stack
Journal:  Mol Cancer Res       Date:  2010-02-09       Impact factor: 5.852

6.  Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases.

Authors:  Oneida A Arosarena; Eric W Barr; Ryan Thorpe; Hilary Yankey; Joseph T Tarr; Fayez F Safadi
Journal:  J Cell Physiol       Date:  2017-04-25       Impact factor: 6.384

7.  Bioluminescent imaging of HPV-positive oral tumor growth and its response to image-guided radiotherapy.

Authors:  Rong Zhong; Matt Pytynia; Charles Pelizzari; Michael Spiotto
Journal:  Cancer Res       Date:  2014-02-13       Impact factor: 12.701

8.  Rab25 regulates invasion and metastasis in head and neck cancer.

Authors:  Panomwat Amornphimoltham; Kamil Rechache; Jamie Thompson; Andrius Masedunskas; Kantima Leelahavanichkul; Vyomesh Patel; Alfredo Molinolo; J Silvio Gutkind; Roberto Weigert
Journal:  Clin Cancer Res       Date:  2013-01-22       Impact factor: 12.531

9.  Targeting mRNA stability arrests inflammatory bone loss.

Authors:  Chetan S Patil; Min Liu; Wenpu Zhao; Derek D Coatney; Fei Li; Elizabeth A VanTubergen; Nisha J D'Silva; Keith L Kirkwood
Journal:  Mol Ther       Date:  2008-08-05       Impact factor: 11.454

10.  Oral squamous carcinoma cells secrete RANKL directly supporting osteolytic bone loss.

Authors:  Xiaoyi Zhang; Carlos Rossa Junior; Min Liu; Fei Li; Nisha J D'Silva; Keith L Kirkwood
Journal:  Oral Oncol       Date:  2012-09-16       Impact factor: 5.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.